🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to message these accounts directly for supplier links, while also obtaining promotional offers.

Active Commerce on Social Networks

Additionally, a flourishing market exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and assertions of next-day UK delivery. Sellers market the drug there before redirecting buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Experts Voice Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals administering products of uncertain source.

Several experts stated the popularity for retatrutide could be connected to the rising price of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, advertising, and consumer laws, risking penalties, prosecution or prison.

Platform Response and Material Removal

Based on the social media company, the platform has taken down violative content and banned associated hashtags and search suggestions. The company said it was dedicated to maintaining the platform secure and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Investigations also discovered groups with up to 9,000 members marketing the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly displays groups with numerous of members, filled with photos of slimming results, glowing testimonials and step-by-step guides for preparing or administering at residence.

After minutes of entering one community, a seller shared WhatsApp details, where most transactions take place. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about weight, medical conditions or past usage.

Product Information and Costs

Inside these groups, messages display black plastic packages with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how long a injector should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for Telegram said it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering materials they can’t verify. Even if the science behind retatrutide is valid, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in interest to current cost increases for approved slimming medications such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has already seen patients harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a company investigational product not yet approved … may subject users to possibly significant medical dangers”.